Cargando…

Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis

To evaluate the effectiveness and safety of Salvianolate injection (SI) in the treatment of acute cerebral infarction (ACI). We electronically searched databases including PubMed, The Cochrane Library, EMBASE, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, and Wan...

Descripción completa

Detalles Bibliográficos
Autores principales: NanZhu, Yang, AiChun, Ju, Xin, Li, XiangHua, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392509/
https://www.ncbi.nlm.nih.gov/pubmed/30461601
http://dx.doi.org/10.1097/MD.0000000000012374
_version_ 1783398488420122624
author NanZhu, Yang
AiChun, Ju
Xin, Li
XiangHua, Yun
author_facet NanZhu, Yang
AiChun, Ju
Xin, Li
XiangHua, Yun
author_sort NanZhu, Yang
collection PubMed
description To evaluate the effectiveness and safety of Salvianolate injection (SI) in the treatment of acute cerebral infarction (ACI). We electronically searched databases including PubMed, The Cochrane Library, EMBASE, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, and WanFang Data to collect randomized controlled trials (RCTs) focused on SI treating ACI up to August 2017. Two reviewers independently screened literatures, extracted data, and assessed the risk of bias of included studies. Then, meta-analysis was performed using RevMan 5.3 software. A total of 39 RCTs involving 4516 patients were included. The results of meta-analysis showed that compared with the Western medicine (WM) therapies group [experimental group (EG)], the total effective rate of SI + WM [control group (CG)] was higher (relative risk = 1.29, 95% CI: 1.24–1.35, P < .00001) in 21 RCTs; SI could improve movement function evaluation scores, including National Institute of Health Stroke Scale, Barthel Index, activities of daily living (P < .00001). There was no significant difference in modified Rankin Scale scores between the 2 groups (P = .008) EG was better than CG in improving Montreal Cognitive Assessment scores (P = .001) and Mini-Mental State Examination scores (P < .00001). SI could improved not only the hemorheology indexes, including plasma viscosity, whole blood high-shear viscosity, whole blood low-shear viscosity, fibrinogen (P < .00001), but also high-sensitivity C-reactive protein and C-reactive protein. EG could achieve a better effect on improving the neural deficit scores (P < .00001). There was no significant difference about adverse drug reactions/adverse drug events between the EG and CG (P = .73). Salvianolate can promote recovery of the motor and cognitive function of patients with ACI. However, due to the limited quality and quantity of included studies, more high-quality studies are needed to verify the above conclusion.
format Online
Article
Text
id pubmed-6392509
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63925092019-03-15 Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis NanZhu, Yang AiChun, Ju Xin, Li XiangHua, Yun Medicine (Baltimore) Research Article To evaluate the effectiveness and safety of Salvianolate injection (SI) in the treatment of acute cerebral infarction (ACI). We electronically searched databases including PubMed, The Cochrane Library, EMBASE, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, and WanFang Data to collect randomized controlled trials (RCTs) focused on SI treating ACI up to August 2017. Two reviewers independently screened literatures, extracted data, and assessed the risk of bias of included studies. Then, meta-analysis was performed using RevMan 5.3 software. A total of 39 RCTs involving 4516 patients were included. The results of meta-analysis showed that compared with the Western medicine (WM) therapies group [experimental group (EG)], the total effective rate of SI + WM [control group (CG)] was higher (relative risk = 1.29, 95% CI: 1.24–1.35, P < .00001) in 21 RCTs; SI could improve movement function evaluation scores, including National Institute of Health Stroke Scale, Barthel Index, activities of daily living (P < .00001). There was no significant difference in modified Rankin Scale scores between the 2 groups (P = .008) EG was better than CG in improving Montreal Cognitive Assessment scores (P = .001) and Mini-Mental State Examination scores (P < .00001). SI could improved not only the hemorheology indexes, including plasma viscosity, whole blood high-shear viscosity, whole blood low-shear viscosity, fibrinogen (P < .00001), but also high-sensitivity C-reactive protein and C-reactive protein. EG could achieve a better effect on improving the neural deficit scores (P < .00001). There was no significant difference about adverse drug reactions/adverse drug events between the EG and CG (P = .73). Salvianolate can promote recovery of the motor and cognitive function of patients with ACI. However, due to the limited quality and quantity of included studies, more high-quality studies are needed to verify the above conclusion. Wolters Kluwer Health 2018-11-21 /pmc/articles/PMC6392509/ /pubmed/30461601 http://dx.doi.org/10.1097/MD.0000000000012374 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
NanZhu, Yang
AiChun, Ju
Xin, Li
XiangHua, Yun
Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis
title Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis
title_full Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis
title_fullStr Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis
title_full_unstemmed Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis
title_short Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis
title_sort salvianolate injection in the treatment of acute cerebral infarction: a systematic review and a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392509/
https://www.ncbi.nlm.nih.gov/pubmed/30461601
http://dx.doi.org/10.1097/MD.0000000000012374
work_keys_str_mv AT nanzhuyang salvianolateinjectioninthetreatmentofacutecerebralinfarctionasystematicreviewandametaanalysis
AT aichunju salvianolateinjectioninthetreatmentofacutecerebralinfarctionasystematicreviewandametaanalysis
AT xinli salvianolateinjectioninthetreatmentofacutecerebralinfarctionasystematicreviewandametaanalysis
AT xianghuayun salvianolateinjectioninthetreatmentofacutecerebralinfarctionasystematicreviewandametaanalysis